Drug intelligence / Profile preview

Digene Total

Development stage
Phase 4
Lead developer
Abbott
Modality
Small Molecules
Administration
Oral
01

Overview

Digene Total is an oral branded formulation of the proton pump inhibitor pantoprazole, marketed for the management of acid‑related gastrointestinal disorders including peptic ulcer disease, gastroesophageal reflux disease (GERD), reflux esophagitis, and associated symptoms such as acidity, heartburn, acid reflux, and pain on swallowing. It contains pantoprazole 40 mg in a gastro‑resistant tablet, which selectively and irreversibly inhibits the gastric parietal cell H+/K+-ATPase (“proton pump”), thereby suppressing basal and stimulated gastric acid secretion and promoting healing of gastric and duodenal ulcers and esophageal lesions. The product is positioned primarily for short‑ and medium‑term control of acid hypersecretion and for ulcers related to chronic NSAID use, with a safety profile typical of PPIs (headache, gastrointestinal disturbances, and long‑term risks such as hypomagnesemia and increased fracture or infection risk).

Brand names
Digene TotalDIGENE TOTAL TABLET
02

Targets

ATP4A (Potassium–transporting ATPase alpha chain 1)

Beyond the preview

Go deeper on Digene Total.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Digene Total.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call